skip to Main Content

Neoadjuvant Strategy Improves Survival in Pancreatic Cancer Resection

Newsfeed image, light gray text on dark gray background
Pancreatic cancer is all too pervasive; it afflicts approximately 55,000 Americans annually, and prognostic indicators show that number is increasing. Although a diagnosis of pancreatic cancer is devastating, one study demonstrated that in some instances patients may live up to 5 times longer than the commonly predicted survival times of 12 to 18 months.

The determining factor appears to depend on a presurgery strategy, according to surgeons at the Mayo Clinic in Rochester, Minnesota. Read more . . .


Back To Top